GLI3 and gastric cancer: GLI3 was mutated in 6.9% of microsatellite-stable gastric cancers [4]: because GLI3 generally functions as a transcriptional repressor (reviewed in [37]), its loss would be expected to lead to a net increase in Gli transcriptional activity.